The first global landscape analysis of multiple sclerosis research funding

Author:

Bebo Bruce1ORCID,Coetzee Tim1ORCID,Gray Emma2,Helme Anne3ORCID,Kanellis Pamela4ORCID,Landsman Douglas1,Mai Michaela5ORCID,Martinez de la Cruz Beatriz6,Morahan Julia7,Plassart Emmanuelle8,Pickrell Baylee9,Rawlings Sarah2,Skovgaard Lasse10,Zaratin Paola11ORCID,Rechtman Lindsay9ORCID

Affiliation:

1. National Multiple Sclerosis Society, New York, NY, USA

2. Multiple Sclerosis Society UK, London, UK

3. Multiple Sclerosis International Federation, London, UK

4. Multiple Sclerosis Canada, Toronto, ON, Canada

5. German Multiple Sclerosis Society, Hannover

6. Esclerosis Multiple Espana, Madrid, Spain

7. Multiple Sclerosis Australia, North Sydney, NSW, Australia

8. Fondation ARSEP–French Multiple Sclerosis Research Society, Ivry-sur-Seine, France

9. McKing Consulting Corporation, Atlanta, GA, USA

10. Danish Multiple Sclerosis Society, Glostrup, Denmark

11. Italian Multiple Sclerosis Society, Genoa, Italy

Abstract

Introduction: Multiple sclerosis (MS) is an immune-mediated central nervous system disorder and a growing global health challenge affecting nearly 3 million people worldwide. Incidence and prevalence continue to increase with no known cause or cure. Globally governments and non-profit organizations fund research toward better understanding of and treatments for multiple sclerosis. Methods: This study identified MS research projects funded between 2021 and 2023 by government and non-profit organization sources. Projects were described by type of scientific approach, Pathways to Cure research category (i.e. Stop, Restore, End), and other key characteristics. Results: Over 2,300 MS research projects were identified through 16 non-profit MS organizations and 18 government databases. The overall global portfolio of these projects is valued at nearly one and a half billion Euros. The majority of projects were classified in the Stop category (60%). Research collaboration occurs in many forms among the research community; around 272 projects were reported to be co-funded. Conclusion: Global MS research collaboration will accelerate progress toward increased knowledge, effective treatments, improved health outcomes, and ultimately cures for MS. This landscape analysis highlights the current distribution of MS research investment between topics and begins to suggest where the MS community should focus to increase potential impact for current and future endeavors.

Publisher

SAGE Publications

Reference12 articles.

1. Pathways to cures for multiple sclerosis: A research roadmap

2. A Quantitative Synthesis of Eight Decades of Global Multiple Sclerosis Research Using Bibliometrics

3. National Multiple Sclerosis Society (NMSS). What causes ms? https://www.nationalmssociety.org/What-is-MS/What-Causes-MS (accessed 7 March 2024).

4. Multiple Sclerosis International Federation (MSIF). Home. International Progressive MS Alliance, https://www.progressivemsalliance.org/ (accessed 7 March 2024).

5. European Charcot Foundation Multiple Sclerosis International Federation (MSIF). Home. PROMS, https://proms-initiative.org/ (accessed 7 March 2024).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Prioritizing global strategies to cure MS;Multiple Sclerosis Journal;2024-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3